| Record Information |
| Version |
3.5 |
| Creation Date |
2006-08-12 15:39:17 -0600 |
| Update Date |
2013-02-08 17:12:35 -0700 |
| HMDB ID |
HMDB03474 |
| Secondary Accession Numbers |
None |
| Metabolite Identification |
| Common Name |
3,5-Diiodo-L-tyrosine |
| Description |
3,5-Diiodo-L-tyrosine is a product from the iodination of monoiodotyrosine. In the biosynthesis of thyroid hormones, diiodotyrosine residues are coupled with other monoiodotyrosine or diiodotyrosine residues to form T4 or T3 thyroid hormones (thyroxine and triiodothyronine). |
| Structure |
Download:
MOL |
SDF |
SMILES |
InChI
Display:
2D Structure |
3D Structure
|
| Synonyms |
- 3,5-Diiodotyrocine
- 3,5-Iodo-L-tyrosine
- 3,5-L-Diiodotyrosine
- 4-Hydroxy-3,5-diiodophenylalanine
- L-3,5-DiioDOTyrosine
- L-Diiodotyrosine
|
| Chemical Formula |
C9H9I2NO3 |
| Average Molecular Weight |
432.9816 |
| Monoisotopic Molecular Weight |
432.867179999 |
| IUPAC Name |
(2S)-2-amino-3-(4-hydroxy-3,5-diiodophenyl)propanoic acid |
| Traditional IUPAC Name |
3,5-diiodotyrosine |
| CAS Registry Number |
300-39-0 |
| SMILES |
N[C@@H](CC1=CC(I)=C(O)C(I)=C1)C(O)=O |
| InChI Identifier |
InChI=1S/C9H9I2NO3/c10-5-1-4(2-6(11)8(5)13)3-7(12)9(14)15/h1-2,7,13H,3,12H2,(H,14,15)/t7-/m0/s1 |
| InChI Key |
NYPYHUZRZVSYKL-ZETCQYMHSA-N |
| Chemical Taxonomy |
| Kingdom |
Organic Compounds |
| Super Class |
Amino Acids, Peptides, and Analogues |
| Class |
Amino Acids and Derivatives |
| Sub Class |
Alpha Amino Acids and Derivatives |
| Other Descriptors |
- Aromatic Homomonocyclic Compounds
- Other amino acids(KEGG)
- dihalogenated L-tyrosine(ChEBI)
- diiodotyrosine(ChEBI)
|
| Substituents |
- Amphetamine Or Derivative
- Aryl Iodide
- Carboxylic Acid
- Iodobenzene
- Organoiodide
- Phenethylamine
- Phenol
- Phenol Derivative
- Primary Aliphatic Amine (Alkylamine)
|
| Direct Parent |
Alpha Amino Acids and Derivatives |
| Ontology |
| Status |
Detected and Quantified |
| Origin |
|
| Biofunction |
- Protein synthesis, amino acid biosynthesis
|
| Application |
Not Available
|
| Cellular locations |
|
| Physical Properties |
| State |
Solid |
| Experimental Properties |
| Property |
Value |
Reference |
| Melting Point |
Not Available |
Not Available |
| Boiling Point |
Not Available |
Not Available |
| Water Solubility |
0.617 mg/mL at 25 °C |
Not Available |
| LogP |
Not Available |
Not Available |
|
| Predicted Properties |
|
| Spectra |
|
| 1H NMR Spectrum |
| MS/MS Spectrum LC-ESI-QQ (API3000, Applied Biosystems) 10 |
| MS/MS Spectrum LC-ESI-QQ (API3000, Applied Biosystems) 20 |
| MS/MS Spectrum LC-ESI-QQ (API3000, Applied Biosystems) 30 |
| MS/MS Spectrum LC-ESI-QQ (API3000, Applied Biosystems) 40 |
| MS/MS Spectrum LC-ESI-QQ (API3000, Applied Biosystems) 50 |
| MS/MS Spectrum LC-ESI-QQ (API3000, Applied Biosystems) 10 |
| MS/MS Spectrum LC-ESI-QQ (API3000, Applied Biosystems) 20 |
| MS/MS Spectrum LC-ESI-QQ (API3000, Applied Biosystems) 30 |
| MS/MS Spectrum LC-ESI-QQ (API3000, Applied Biosystems) 40 |
| MS/MS Spectrum LC-ESI-QQ (API3000, Applied Biosystems) 50 |
| MS/MS Spectrum GC-MS |
| [1H,13C] 2D NMR Spectrum |
|
| Biological Properties |
| Cellular Locations |
|
| Biofluid Locations |
|
| Tissue Location |
Not Available
|
| Pathways |
|
| Normal Concentrations |
|
| Blood |
Detected and Quantified |
|
0.0036 (0.0014-0.0099) uM |
Adult (>18 years old) |
Both |
Normal
|
|
| Urine |
Detected and Quantified |
|
0.000049 +/- 0.000027 umol/mmol creatinine |
Adult (>18 years old) |
Both |
Normal
|
|
|
| Abnormal Concentrations |
|
| Blood |
Detected and Quantified |
|
0.0036 (0.0010-0.0134) uM |
Adult (>18 years old) |
Both |
Hyperthyroidism
|
|
| Urine |
Detected and Quantified |
|
0.00013 +/- 0.000098 umol/mmol creatinine |
Adult (>18 years old) |
Both |
Chronic renal disease
|
|
|
| Associated Disorders and Diseases |
| Disease References |
| Hyperthyroidism |
- Nelson JC, Weiss RM, Lewis JE, Wilcox RB, Palmer FJ: A multiple ligand-binding radioimmunoassay of diiodotyrosine. J Clin Invest. 1974 Feb;53(2):416-22.
Pubmed: 11344555
|
| Chronic kidney disease |
- Ramsden DB, Farmer M, Mohammed MN, McGonigle RS, Sheppard MC: 3,5-Diiodotyrosine and thyronine in the urine of patients with chronic renal disease. Clin Endocrinol (Oxf). 1986 May;24(5):491-5.
Pubmed: 3098453
|
|
| Associated OMIM IDs |
None |
| External Links |
| DrugBank ID |
Not Available |
| DrugBank Metabolite ID |
Not Available |
| Phenol Explorer Compound ID |
Not Available |
| Phenol Explorer Metabolite ID |
Not Available |
| FoodDB ID |
FDB023181 |
| KNApSAcK ID |
Not Available |
| Chemspider ID |
8946  |
| KEGG Compound ID |
C01060  |
| BioCyc ID |
DIIODO-L-TYROSINE  |
| BiGG ID |
36719  |
| Wikipedia Link |
Not Available |
| NuGOwiki Link |
HMDB03474  |
| Metagene Link |
HMDB03474  |
| METLIN ID |
6940  |
| PubChem Compound |
9305  |
| PDB ID |
TYI  |
| ChEBI ID |
15768  |
| References |
| Synthesis Reference |
Savitskii, A. Ya. The preparation and properties of 3,5-diiodo-l-tyrosine. Zhurnal Obshchei Khimii (1939), 9 1342-4. |
| Material Safety Data Sheet (MSDS) |
Download (PDF)
|
| General References |
- Ismail-Beigi F, Rahimifar M: A variant of iodotyrosine-dehalogenase deficiency. J Clin Endocrinol Metab. 1977 Mar;44(3):499-506.
Pubmed: 838849
- Bismuth J, Castay M, Lissitzky S: Binding of 3,5-diiodotyrosine to serum proteins. Clin Chim Acta. 1976 Jun 15;69(3):417-22.
Pubmed: 59643
- Tompkins RK, Croke JC: Bile acids inhibit pepsin activity against a refined substrate. Am J Surg. 1980 Feb;139(2):237-9.
Pubmed: 6766680
|